Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Obesity
is a major health problem worldwide and constitutes a sanitary emergency in Mexico, especially childhood
obesity
. Several studies have proved the relationship between
obesity
and oxidative stress and the influence of genetic predisposition. This work was aimed to analyze the association of antioxidant enzyme polymorphisms with overweight and
obesity
in Mexican children and adolescents. A case-control study was performed in 585 children and adolescents aged 3 to 17 years, using two criteria to classify
obesity
: body mass index (BMI) and body fat percentage (BFP). Anthropometric and biochemical measurements were carried out, and malondialdehyde serum levels were determined. Genotyping was done with the Axiom Genome-Wide LAT microarray, including 68 single nucleotide polymorphisms (SNPs) of the glutathione peroxidase (GPX) and paraoxonase (PON) families. We found six haplotypes associated with
obesity
-two of them (one in GPX3 and the other in GPX5 and
GPX6
) in a protective direction when
obesity
was classified by BMI. The other four haplotypes were associated with
obesity
when classification was based on BFP-one of them in GPX3 in a protective direction and the others in PON genes conferring
obesity
risk. In addition, two SNPs, GPX3 rs922429 and GPX4 rs2074451 showed protection against
obesity
classified by BFP. This study showed genetic susceptibility to oxidative stress in relation to
obesity
in Mexican children and opens up the possibility that some genetic loci related to
obesity
are not identified when weight classification is based on BMI.
...
PMID:Antioxidant Enzymes Haplotypes and Polymorphisms Associated with Obesity in Mexican Children. 3275 12